Dr. Maxime Rousseaux is an assistant professor and Canada Research Chair at the University of Ottawa. He obtained his PhD in neuroscience under Dr. David Park’s supervision in Ottawa. There, his research focused on identifying mechanisms of neurodegeneration in preclinical models of Parkinson’s disease (PD). In 2012, Dr. Rousseaux joined Dr. Huda Zoghbi’s laboratory at Baylor College of Medicine to pursue a postdoctoral fellowship. During that time, he focused on identifying novel regulators of alpha-synuclein levels using genetic screens to gain novel therapeutic entry points for synucleinopathy disorders. In 2018, he returned to the University of Ottawa to start his own lab with a focus on studying how improper protein localization can be linked to neurodegenerative diseases such as PD. His group has an affinity for generating new preclinical models that depict different aspects of PD and examining how genetic and environmental factors converge on PD etiology.